The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
This is not the kind of honor I ever anticipated on my life bingo card. But I never expected a Parkinson’s disease diagnosis, either. Or starting a foundation that bears my name, which has ...
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...
In the end, I have to be my best advocate for my own care. It took years, but when I became my best advocate, serious change happened,” Choi says.